Nuvectis Pharma, Inc. (NVCT) - Wutah bathi EPS kuartalan

Simbol resmi perusahaan Nuvectis Pharma (NVCT)

Nuvectis Pharma, Inc. (NVCT) focuses on independent testing of its own molecules without external partnerships. Experienced management rapidly allocates capital to complete clinical stages. Tracking the shift in quarterly EPS levels on GURU.Markets, we note that the value -133.80 reflects the current figure. Nuvectis Pharma, Inc. (NVCT) attracts leading scientists with ambitious R&D objectives, guaranteeing them high autonomy and lucrative stock option programs.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Nuvectis Pharma (NVCT): kanggo periode 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Nuvectis Pharma, Inc.

Analisis fundamental perusahaan:nuvectis.com, NVCT
Produk asil prodhuksi Nuvectis Pharma, Inc

Nuvectis Pharma, Inc. (NVCT) focuses on developing targeted therapies for the treatment of rare oncological diseases. This indicator measures the percentage change in net earnings per share compared to the same period last year. Growth in this metric confirms the effectiveness of investments in science and the future commercialization of drugs. A positive trend signals an increase in the cost of capital. By analyzing the quarterly growth in earnings per share, an investor can determine the optimal entry point, avoiding purchases at local peaks.

Analisis perusahaan pesaing

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan dayonebio.com (DAWN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Monopar Corp (MNPR)|INBX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan I-Mab Inc. IMAB|Fennec - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|HRTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan coherus.com|CRBP: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Cardiff Oncology, Inc. CRDF|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BYSI|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BioAtla BCAB|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan LIXT (Lixte Biotechnology)|CTXR (Citius Pharma) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Cellectar Biosciences - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan BLRX (BioLineRx)|Can-Fite BioPharma, Ltd. - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan APRE (aprea.com)|KZIA: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Silexion (SLXN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nucana.com|CMRX: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CYCC|Wutah bathi EPS kuartalan G1 Therapeutics Inc. (GTHX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kronos Bio Corp KRON|KTRA (Kintara Therapeutics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|ONCT: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc